drugset / Trial / NCT00008372

Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer

NCT00008372 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have small cell lung cancer that has not responded to platinum-based chemotherapy.

Timeline

Start
2000-12
Primary completion
2002-09
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject CHLORSULFAQUINOXALINE Small molecule — Intravenous

Indications